NMC

NEA Management Company Portfolio holdings

AUM $1.33B
This Quarter Return
+22.8%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$2.23B
AUM Growth
+$2.23B
Cap. Flow
-$87.1M
Cap. Flow %
-3.91%
Top 10 Hldgs %
83.23%
Holding
40
New
1
Increased
2
Reduced
4
Closed
1

Top Buys

1
ARDX icon
Ardelyx
ARDX
$29.6M
2
KA
Kineta, Inc. Common Stock
KA
$7.2M
3
XCOM
XTERA COMMUNICATIONS INC COM STK (DE)
XCOM
$2M
4
OREX
Orexigen Therapeutics, Inc.
OREX
$1.11M

Top Sells

1
GRPN icon
Groupon
GRPN
$67.1M
2
EXEL icon
Exelixis
EXEL
$17.2M
3
LOXO
Loxo Oncology, Inc
LOXO
$13.2M
4
ZSAN
Zosano Pharma Corporation
ZSAN
$82.4K

Sector Composition

1 Healthcare 79.75%
2 Technology 6.13%
3 Communication Services 4.64%
4 Consumer Discretionary 1.46%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
VIRX
26
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$5.67M 0.25%
1,298,274
-6,491,370
-83% –
DZSI
27
DELISTED
DZS Inc. Common Stock
DZSI
$5.45M 0.24%
4,781,290
– –
ARQL
28
DELISTED
Arqule Inc
ARQL
$4.51M 0.2%
2,520,316
– –
ORKA
29
Oruka Therapeutics, Inc. Common Stock
ORKA
$578M
$4.13M 0.19%
1,460,209
– –
AKTX
30
Akari Therapeutics
AKTX
$21.4M
$3.85M 0.17%
452,167
– –
CSBR icon
31
Champions Oncology
CSBR
$95.8M
$2.63M 0.12%
1,562,500
– –
AVTX icon
32
Avalo Therapeutics
AVTX
$139M
$2.52M 0.11%
595,435
– –
ROKA
33
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
$2.22M 0.1%
3,220,433
– –
XCOM
34
DELISTED
XTERA COMMUNICATIONS INC COM STK (DE)
XCOM
$2M 0.09%
+3,631,537
New +$2M
ZSAN
35
DELISTED
Zosano Pharma Corporation
ZSAN
$1.6M 0.07%
2,052,809
-105,734
-5% -$82.4K
OREX
36
DELISTED
Orexigen Therapeutics, Inc.
OREX
$1.23M 0.06%
370,900
– +$1.11M
AGRX
37
DELISTED
Agile Therapeutics, Inc
AGRX
$932K 0.04%
133,488
– –
PRTK
38
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$862K 0.04%
66,245
– –
GYRE icon
39
Gyre Therapeutics
GYRE
$734M
$789K 0.04%
652,380
– –
EXEL icon
40
Exelixis
EXEL
$9.95B
– –
-2,207,000
Closed -$17.2M
1
2